AAAAAA

   
Results: 1-13 |
Results: 13
ETHNIC-DIFFERENCES IN THE GLYCEMIC RESPONSE TO EXOGENOUS INSULIN-TREATMENT IN THE VETERANS AFFAIRS COOPERATIVE STUDY IN TYPE-2 DIABETES-MELLITUS (VA CSDM)
Authors: AGRAWAL L EMANUELE NV ABRAIRA C HENDERSON WG LEVIN SR SAWIN CT SILBERT CK NUTTALL FQ COMSTOCK JP COLWELL JA
Citation: L. Agrawal et al., ETHNIC-DIFFERENCES IN THE GLYCEMIC RESPONSE TO EXOGENOUS INSULIN-TREATMENT IN THE VETERANS AFFAIRS COOPERATIVE STUDY IN TYPE-2 DIABETES-MELLITUS (VA CSDM), Diabetes care, 21(4), 1998, pp. 510-515
RESPONSE TO INTENSIVE THERAPY STEPS AND TO GLIPIZIDE DOSE IN COMBINATION WITH INSULIN IN TYPE-2 DIABETES - VA FEASIBILITY STUDY ON GLYCEMICCONTROL AND COMPLICATIONS (VA CSDM)
Authors: ABRAIRA C HENDERSON WG COLWELL JA NUTTALL FQ COMSTOCK JP EMANUELE NV LEVIN SR SAWIN CT SILBERT CK
Citation: C. Abraira et al., RESPONSE TO INTENSIVE THERAPY STEPS AND TO GLIPIZIDE DOSE IN COMBINATION WITH INSULIN IN TYPE-2 DIABETES - VA FEASIBILITY STUDY ON GLYCEMICCONTROL AND COMPLICATIONS (VA CSDM), Diabetes care, 21(4), 1998, pp. 574-579
TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) INHIBIT THE EXPRESSION AND ACTIVITY OF NA+ K+-ATPASE IN FRTL-5 RAT-THYROID CELLS/
Authors: PEKARY AE LEVIN SR JOHNSON DG BERG L HERSHMAN JM
Citation: Ae. Pekary et al., TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) INHIBIT THE EXPRESSION AND ACTIVITY OF NA+ K+-ATPASE IN FRTL-5 RAT-THYROID CELLS/, Journal of interferon & cytokine research, 17(4), 1997, pp. 185-195
SULFONYLUREAS BIND TO THE BETA-SUBUNIT OF NA(+)K(+)ATPASE AND INHIBITITS ACTIVITY
Authors: LEVIN SR MIRELL CJ VOSKANYAN G RIBALET B NAGY AK
Citation: Sr. Levin et al., SULFONYLUREAS BIND TO THE BETA-SUBUNIT OF NA(+)K(+)ATPASE AND INHIBITITS ACTIVITY, Diabetes, 46, 1997, pp. 827-827
CARDIOVASCULAR EVENTS AND CORRELATES IN THE VETERANS AFFAIRS DIABETESFEASIBILITY TRIAL - VETERANS AFFAIRS COOPERATIVE STUDY ON GYLCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES
Authors: ABRAIRA C COLWELL J NUTTALL F SAWIN CT HENDERSON W COMSTOCK JP EMANUELE NV LEVIN SR PACOLD I LEE HS SILBERT CK CXYPOLISKI R VASQUEZ M KERNAN D NIEWOEHNER C BACKES M BRADLEY M BRADLEY M CROW R RUBINO F BUSHNELL D PFEIFER M SERVICE FJ HOWARD B CHEW E HOOGWERF B SEIGEL D CLARK CM OLEFSKY JM PORTE D SUSSMAN KE JOHNSON N CHRISTINE B TIR K SATHER M DAY P MORGAN N DEYKIN D GOLD J HUANG P
Citation: C. Abraira et al., CARDIOVASCULAR EVENTS AND CORRELATES IN THE VETERANS AFFAIRS DIABETESFEASIBILITY TRIAL - VETERANS AFFAIRS COOPERATIVE STUDY ON GYLCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES, Archives of internal medicine, 157(2), 1997, pp. 181-188
GLIMEPIRIDE, A NEW ONCE-DAILY SULFONYLUREA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF NIDDM PATIENTS
Authors: ROSENSTOCK J SAMOLS E MUCHMORE DB SCHNEIDER J ABELOVE WA ASPLIN CM BERGSTROM RW BERHANU P BOROWSKI GD BROWNING GV COMSTOCK JP FRIEDMAN NM GOLLAPUDI GM GRABER AL GUTHRIE RA HENSON BE HERSHON KS KROSNICK A LEVIN SR LEVY P LOCK JP LODEWICK PA MERSEY JH MICHIE DD MATHER SR MUSEY VC PALMER JP PETERS PJ POULOS JT PRENDERGAST JJ REYNOLDS LR ROBERTS VL ROSENBLATT S ROSENTHAL AR CAVANAUGH JJ SCHNEIDER SH SNYDER JW SWEET RA VESTAL RE
Citation: J. Rosenstock et al., GLIMEPIRIDE, A NEW ONCE-DAILY SULFONYLUREA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF NIDDM PATIENTS, Diabetes care, 19(11), 1996, pp. 1194-1199
SULFONYLUREA BINDING TO A LOW-AFFINITY SITE INHIBITS THE NA K-ATPASE AND THE K-ATP CHANNEL IN INSULIN-SECRETING CELLS/
Authors: RIBALET B MIRELL CJ JOHNSON DG LEVIN SR
Citation: B. Ribalet et al., SULFONYLUREA BINDING TO A LOW-AFFINITY SITE INHIBITS THE NA K-ATPASE AND THE K-ATP CHANNEL IN INSULIN-SECRETING CELLS/, The Journal of general physiology, 107(2), 1996, pp. 231-241
GLYCEMIC CONTROL RETARDS PROGRESSION OF ALBUMINURIA IN NIDDM
Authors: LEVIN SR COBURN J ABRAIRA C COLWELL J COMSTOCK J NUTTALL F HENDERSON W EMANUELE N SAWIN C
Citation: Sr. Levin et al., GLYCEMIC CONTROL RETARDS PROGRESSION OF ALBUMINURIA IN NIDDM, Diabetes, 45, 1996, pp. 4-4
VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL
Authors: ABRAIRA C COLWELL JA NUTTALL FQ SAWIN CT NAGEL NJ COMSTOCK JP EMANUELE NV LEVIN SR HENDERSON W LEE HS
Citation: C. Abraira et al., VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL, Diabetes care, 18(8), 1995, pp. 1113-1123
CONTINUOUS INSULIN INFUSIONS IN NEONATES - PHARMACOLOGICAL AVAILABILITY OF INSULIN IN INTRAVENOUS SOLUTIONS
Authors: SIMEON PS GEFFNER ME LEVIN SR LINDSEY AM
Citation: Ps. Simeon et al., CONTINUOUS INSULIN INFUSIONS IN NEONATES - PHARMACOLOGICAL AVAILABILITY OF INSULIN IN INTRAVENOUS SOLUTIONS, The Journal of pediatrics, 124(5), 1994, pp. 818-820
INHIBITION OF RAT PANCREATIC-ISLET NA+K+TPASE BY TOLBUTAMIDE
Authors: LEVIN SR JOHNSON DG MIRELL CJ RIBALET B
Citation: Sr. Levin et al., INHIBITION OF RAT PANCREATIC-ISLET NA+K+TPASE BY TOLBUTAMIDE, Clinical research, 42(1), 1994, pp. 10000046-10000046
FACTORS ASSOCIATED WITH MICROALBUMINURIA IN TYPE-II DIABETES
Authors: LEVIN SR COBURN JW
Citation: Sr. Levin et Jw. Coburn, FACTORS ASSOCIATED WITH MICROALBUMINURIA IN TYPE-II DIABETES, Diabetes, 42, 1993, pp. 197-197
MORPHOLOGIC BASIS FOR LOSS OF REGULATED INSULIN-SECRETION BY ISOLATEDRAT PANCREATIC-ISLETS
Authors: PAI GM SLAVIN BG TUNG P VOLK BW JOHNSON DG ANDERSON DG LEVIN SR
Citation: Gm. Pai et al., MORPHOLOGIC BASIS FOR LOSS OF REGULATED INSULIN-SECRETION BY ISOLATEDRAT PANCREATIC-ISLETS, The Anatomical record, 237(4), 1993, pp. 498-505
Risultati: 1-13 |